Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma

被引：27
作者：
Rocchi, Serena [1 ]
Tacchetti, Paola [1 ]
Pantani, Lucia [1 ]
Mancuso, Katia [1 ]
Zannetti, Beatrice [1 ]
Cavo, Michele [1 ]
Zamagni, Elena [1 ]
机构：
[1] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 06期
关键词：
DEXAMETHASONE; MONOTHERAPY; LENALIDOMIDE; MANAGEMENT; CD38;
D O I：
10.3324/haematol.2018.191122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E277 / E278
页数：2
相关论文
共 15 条
  • [1] Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
    Berdeja, Jesus
    Jagannath, Sunday
    Zonder, Jeffrey
    Badros, Ashraf
    Kaufman, Jonathan L.
    Manges, Robert
    Gupta, Manish
    Tendolkar, Amol
    Lynch, Mark
    Bleickardt, Eric
    Paliwal, Prashni
    Vij, Ravi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (03) : 129 - 138
  • [2] Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment
    Chanan-Khan, Asher A.
    San Miguel, Jesus F.
    Jagannath, Sundar
    Ludwig, Heinz
    Dimopoulos, Meletios A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2145 - 2163
  • [3] Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Chari, Ajai
    Suvannasankha, Attaya
    Fay, Joseph W.
    Arnulf, Bertrand
    Kaufman, Jonathan L.
    Ifthikharuddin, Jainulabdeen J.
    Weiss, Brendan M.
    Krishnan, Amrita
    Lentzsch, Suzanne
    Comenzo, Raymond
    Wang, Jianping
    Nottage, Kerri
    Chiu, Christopher
    Khokhar, Nushmia Z.
    Ahmadi, Tahamtan
    Lonial, Sagar
    [J]. BLOOD, 2017, 130 (08) : 974 - 981
  • [4] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14) : 1319 - 1331
  • [5] Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenstrom's macroglobulinemia.
    Dimopoulos, Meletios A.
    Tedeschi, Alessandra
    Trotman, Judith
    Garcia-Sanz, Ramon
    MacDonald, David
    Leblond, Veronique
    Mahe, Beatrice
    Herbaux, Charles
    Tam, Constantine
    Palomba, Maria Lia
    Matous, Jeffrey
    Shustik, Chaim
    Kastritis, Efstathios
    Treon, Steven P.
    Li, Jianling
    Salman, Zeena
    Graef, Thorsten
    Buske, Christian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
    Dimopoulos, Meletios A.
    Sonneveld, Pieter
    Leung, Nelson
    Merlini, Giampaolo
    Ludwig, Heinz
    Kastritis, Efstathios
    Goldschmidt, Hartmut
    Joshua, Douglas
    Orlowski, Robert Z.
    Powles, Raymond
    Vesole, David H.
    Garderet, Laurent
    Einsele, Hermann
    Palumbo, Antonio
    Cavo, Michele
    Richardson, Paul G.
    Moreau, Philippe
    San Miguel, Jesus
    Rajkumar, S. Vincent
    Durie, Brian G. M.
    Terpos, Evangelos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1544 - +
  • [7] Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients
    Gran, Charlotte
    Gahrton, Gosta
    Alici, Evren
    Nahi, Hareth
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (04) : 386 - 388
  • [8] Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
    Krejcik, Jakub
    Casneuf, Tineke
    Nijhof, Inger S.
    Verbist, Bie
    Bald, Jaime
    Plesner, Torben
    Syed, Khaja
    Liu, Kevin
    van de Donk, Niels W. C. J.
    Weiss, Brendan M.
    Ahmadi, Tahamtan
    Lokhorst, Henk M.
    Mutis, Tuna
    Sasser, A. Kate
    [J]. BLOOD, 2016, 128 (03) : 384 - 394
  • [9] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
    Kumar, Shaji
    Paiva, Bruno
    Anderson, Kenneth C.
    Durie, Brian
    Landgren, Ola
    Moreau, Philippe
    Munshi, Nikhil
    Lonial, Sagar
    Blade, Joan
    Mateos, Maria-Victoria
    Dimopoulos, Meletios
    Kastritis, Efstathios
    Boccadoro, Mario
    Orlowski, Robert
    Goldschmidt, Hartmut
    Spencer, Andrew
    Hou, Jian
    Chng, Wee Joo
    Usmani, Saad Z.
    Zamagni, Elena
    Shimizu, Kazuyuki
    Jagannath, Sundar
    Johnsen, Hans E.
    Terpos, Evangelos
    Reiman, Anthony
    Kyle, Robert A.
    Sonneveld, Pieter
    Richardson, Paul G.
    McCarthy, Philip
    Ludwig, Heinz
    Chen, Wenming
    Cavo, Michele
    Harousseau, Jean-Luc
    Lentzsch, Suzanne
    Hillengass, Jens
    Palumbo, Antonio
    Orfao, Alberto
    Rajkumar, S. Vincent
    Miguel, Jesus San
    Avet-Loiseau, Herve
    [J]. LANCET ONCOLOGY, 2016, 17 (08) : E328 - E346
  • [10] Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Dingli, David
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Leung, Nelson
    Dispenzieri, Angela
    Kourelis, Taxiarchis V.
    Go, Ronald S.
    Lacy, Martha Q.
    Hobbs, Miriam A.
    Lin, Yi
    Warsame, Rahma
    Lust, John
    Fonder, Amie L.
    Hwa, Yi L.
    Hayman, Suzanne R.
    Russell, Stephen J.
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1146 - 1155
12